ArticleCureus2026
Late-Onset Episodic Weakness With Hyperkalemia Suggestive of Hyperkalemic Periodic Paralysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A rare late-onset presentation of episodic weakness associated with hyperkalemia is described in a 72-year-old male with concurrent early-stage chronic lymphocytic leukemia. He experienced frequent episodes of generalized muscle weakness accompanied by loss of speech, shortness of breath, and fatigue, with a documented serum potassium level of 6.5 mmol/L obtained within 30 minutes of an attack. Treatment with acetazolamide and dietary modification was associated with a substantial reduction in episode frequency and improved functional status, although persistent fatigue remained. The clinical presentation was suggestive of hyperkalemic periodic paralysis, but a definitive diagnosis was limited by the patient's exceptionally late age at onset, negative genetic testing, lack of specialized exercise testing, and absence of electrophysiologic testing during an attack. This case emphasizes the importance of considering hyperkalemic periodic paralysis in the differential diagnosis of episodic weakness while simultaneously evaluating alternative neuromuscular, metabolic, hematologic, and paraneoplastic causes. Treatment response to acetazolamide and dietary modification was considered supportive of but not necessarily diagnostic of an inherited channelopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.